Company Filing History:
Years Active: 2010-2013
Title: Michael Lindenmuth: Innovator in Chemical Compounds
Introduction
Michael Lindenmuth is a notable inventor based in King of Prussia, Pennsylvania. He holds three patents, showcasing his contributions to the field of chemical compounds. His work primarily focuses on novel indole carboxamide derivatives, which have significant implications in medical treatments.
Latest Patents
Lindenmuth's latest patents involve the development of chemical compounds that act as inhibitors of IKK2. These compounds are particularly useful in treating disorders associated with inappropriate IKK2 activity, such as rheumatoid arthritis, asthma, and chronic obstructive pulmonary disease (COPD). The inventions also encompass pharmaceutical compositions that include these compounds, along with methods for inhibiting IKK2 activity and treating related disorders.
Career Highlights
Throughout his career, Michael Lindenmuth has worked with prominent companies, including GlaxoSmithKline LLC and Glaxo Group Limited. His experience in these organizations has contributed to his expertise in the pharmaceutical field and his ability to innovate in chemical compounds.
Collaborations
Some of his notable coworkers include Jeffrey K Kerns and Sonia M Thomas. Their collaboration has likely played a role in advancing the research and development of the compounds he has patented.
Conclusion
Michael Lindenmuth's work in the field of chemical compounds demonstrates his commitment to innovation and improving medical treatments. His patents reflect significant advancements that can benefit patients suffering from various disorders.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.